SENATE 637116th CongressRead twice and referred to the Committee on Health, Education, Labor, and Pensions.
CURE High Drug Prices Act
- Last Action
- 2/28/2019
Actions
- 2019-02-28Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2019-02-28Introduced in Senate
CRS Summary
As of 2019-02-28 (00)
Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act
This bill prohibits price gouging by manufacturers of prescription drugs (including a combination of a drug, device, or biological product) that are covered by a federal health care program. The bill specifies percentage increases in price at which price gouging is presumed.
Cosponsors (5)
- Jeff Merkley (D-OR)
- Kamala Harris (D-CA)
- Amy Klobuchar (D-MN)
- Brian Schatz (D-HI)
- Bernard Sanders (I-VT)
Subjects
- Administrative remedies
- Civil actions and liability
- Health care costs and insurance
- Health care coverage and access
- Health programs administration and funding
- Inflation and prices
- Prescription drugs
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.